
First Human Trial Of Antibody Treatment For COVID-19 Begins
Eli Lilly and Company said Monday it has started the first human trial of an antibody therapy designed to treat
Eli Lilly and Company said Monday it has started the first human trial of an antibody therapy designed to treat